End-to-end CDMO BePharBel Manufacturing offers integrated development and manufacturing under European GMP for both small molecules and sterile/non-sterile products, creating opportunities to become a strategic CDMO partner for pharma and biotech companies seeking streamlined regulatory-compliant production and formulation development.

Specialized Delivery Their innovative MMCR multi-layer micro-particle controlled release platform enables development of swallow-friendly, controlled release syrups, presenting a compelling selling point for customers targeting pediatric and elderly populations with swallowing impairments.

Therapeutic Focus Active portfolio as a Marketing Authorisation Holder in Rx, OTC, and dietary supplements, with emphasis on ophthalmology and dermatology, suggests cross-sell opportunities to partners in these therapeutic areas seeking manufacturing, packaging, and regulatory support.

Regional Footprint Operations in Belgium and Luxembourg combined with a broad European GMP capability position BePharBel as a convenient European manufacturing and regulatory hub for European-focused brands looking to accelerate time-to-market in the region.

Small to Medium Scale With a workforce of up to 200 and revenue in the lower multi-million bracket, BePharBel is well-suited for mid-size biotech and specialty pharma partners seeking flexible, collaborative development programs and cost-efficient manufacturing without the scale-up risk of larger CDMOs.